Cargando…

The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort

Detalles Bibliográficos
Autores principales: Sendi, Parham, Branca, Mattia, Büchi, Annina Elisabeth, Widmer, Nadja, Tande, Aaron J., Gowland, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444149/
https://www.ncbi.nlm.nih.gov/pubmed/36067942
http://dx.doi.org/10.1016/j.cmi.2022.08.019
_version_ 1784783152519053312
author Sendi, Parham
Branca, Mattia
Büchi, Annina Elisabeth
Widmer, Nadja
Tande, Aaron J.
Gowland, Peter
author_facet Sendi, Parham
Branca, Mattia
Büchi, Annina Elisabeth
Widmer, Nadja
Tande, Aaron J.
Gowland, Peter
author_sort Sendi, Parham
collection PubMed
description
format Online
Article
Text
id pubmed-9444149
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-94441492022-09-06 The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort Sendi, Parham Branca, Mattia Büchi, Annina Elisabeth Widmer, Nadja Tande, Aaron J. Gowland, Peter Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022-12 2022-09-05 /pmc/articles/PMC9444149/ /pubmed/36067942 http://dx.doi.org/10.1016/j.cmi.2022.08.019 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Sendi, Parham
Branca, Mattia
Büchi, Annina Elisabeth
Widmer, Nadja
Tande, Aaron J.
Gowland, Peter
The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
title The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
title_full The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
title_fullStr The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
title_full_unstemmed The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
title_short The disease burden of Delta and Omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
title_sort disease burden of delta and omicron variants of severe acute respiratory syndrome coronavirus 2 in a predominantly vaccinated and healthy cohort
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444149/
https://www.ncbi.nlm.nih.gov/pubmed/36067942
http://dx.doi.org/10.1016/j.cmi.2022.08.019
work_keys_str_mv AT sendiparham thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT brancamattia thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT buchianninaelisabeth thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT widmernadja thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT tandeaaronj thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT gowlandpeter thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT thediseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT sendiparham diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT brancamattia diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT buchianninaelisabeth diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT widmernadja diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT tandeaaronj diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT gowlandpeter diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort
AT diseaseburdenofdeltaandomicronvariantsofsevereacuterespiratorysyndromecoronavirus2inapredominantlyvaccinatedandhealthycohort